ZOLMITRIPTAN - ORAL (zol-meh-TRIP-tan)
COMMON BRAND NAME(S):
This medication is used to treat acute migraine attacks. This drug does not prevent future migraine attacks.
HOW TO USE THIS MEDICATION:
Take this drug by mouth as directed for migraine headache. If the headache returns, the dose may be repeated after 2 hours if so directed by your doctor. If you have no relief with the first dose, do not take a second dose without consulting your doctor. Do not exceed 10mg in a 24 hour period.
Nausea, headache, sweating, dizziness and drowsiness may occur. If these effects persist or worsen, notify your doctor promptly. Report promptly:
unusually cold/tingling or numb hands or feet. Unlikely but report promptly:
chest/neck or stomach discomfort, bloody diarrhea, unusual weakness, mental/mood changes, eye discomfort. Very unlikely but report promptly:
unusually fast or slow heartbeat, confusion, fainting. In the unlikely event you have an allergic reaction to this drug, seek immediate medical attention. Symptoms of an allergic reaction include:
rash, itching, swelling, dizziness, trouble breathing. If you notice other effects not listed above, contact your doctor or pharmacist.
Before using this drug, tell your doctor your medical history, including:
allergies (especially drug allergies), heart or blood vessel problems, high blood pressure, High cholesterol, intestine or liver disease, diabetes, smoking, history of heart problems (including family history). Limit alcohol intake, as it may aggravate certain side effects. Caution is advised before performing hazardous tasks (e.g., driving) while using this drug. This medication should be used only when clearly needed during pregnancy. Discuss the risks and benefits with your doctor. It is not known whether this drug is excreted into breast milk. Consult your doctor before breast-feeding.
Tell your doctor of all nonprescription and prescription medication you may use, especially:
cimetidine, other “serotonin-type” drugs (e.g., “SSRI” antidepressants such as fluoxetine); MAO inhibitors (e.g., furazolidone, linezolid, phenelzine, selegiline, tranylcypromine), moclobemide, “triptan” drugs (e.g., sumatriptan). Also, report use of “ergot-type” drugs (e.g., ergotamine, dihydroergotamine, methysergide), venlafaxine, nefazodone, sibutramine. Tell your doctor if you take any drowsiness-causing medicine such as:
sleep aids, tranquilizers, anti-seizure drugs, muscle relaxants, narcotic pain relievers (e.g., codeine), psychiatric drugs, certain antihistamines (found in over-the-counter products such as diphenhydramine). Do not use this drug within 24 hours of any “ergot-type” or “serotonin-type” drugs. Do not use this drug together with an MAO inhibitor or within two weeks of stopping an MAO inhibitor. Do not start or stop any medicine without doctor or pharmacist approval.
If overdose is suspected, contact your local poison control center or emergency room immediately. Symptoms of overdose may include drowsiness.
Do not share this medication with others. Medical tests will be done to monitor for drug side effects.
Store at room temperature between 68 and 77 degrees F (20-25 degrees C) away from light and moisture.
Revision date: June 20, 2011
Last revised: by Janet A. Staessen, MD, PhD
Drugs & Medications
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.
The drug reference included in this section is provided by Cerner Multum, Inc., of Denver, Colorado. Armenian Medical Network receives monthly updates from Multum.